A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）

NCT04420130 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Failed to pass ethics committee review

Conditions

Pancreatic Cancer
Liver Metastasis

Interventions

DRUG: Camrelizumab
DRUG: Chemotherapy
PROCEDURE: Ablation

Sponsor

Yanqiao Zhang